{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Computed using the Kaplan-Meier method. Ninety-five percent confidence intervals will be constructed and selected results will be illustrated using figures and plots.","groups":[{"description":"Patients receive belinostat IV over 30 minutes on days 1-5. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.\n\nbelinostat: Given IV","id":"OG000","title":"Treatment (Enzyme Inhibitor Therapy)"}],"populationDescription":"Data were not collected","reportingStatus":"POSTED","timeFrame":"Up to 5 years","title":"Overall Survival","type":"SECONDARY"}